Integrative Medicine Institute

Integrative Medicine Institute (IMI) is a clinical research and consulting organization founded in 1992 by Dr. David Riley. The institute focuses on practice-based research, clinical trial management, and the development of evidence-based reporting guidelines, such as the CARE guidelines for case reports. IMI has been a key player in the development of integrative therapies, sponsoring and conducting clinical trials for products like topical zinc and walnut extracts for the treatment of herpes simplex labialis. The organization also provides editorial services and professional training through its Scientific Writing in Health and Medicine (SWIHM) division. IMI operates globally, collaborating with academic institutions and industry partners to bridge the gap between conventional and integrative medicine.